Date: 24th July 2012
London, United Kingdom, July 24 2012 – DNA Electronics Ltd, a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be sharing his vision for the future of the life sciences sector at the upcoming Healthcare and Life Sciences Global Business Summit being hosted by UK Trade & Investment (UKTI) at Lancaster House in London on Thursday 2nd August 2012. Professor Toumazou will join other key innovators, dignitaries and industry figures from the UK life sciences community who have been invited to address delegates on the future of the sector.
The UKTI-run summit, entitled “Rising to the Healthcare Challenges of the Next Decade – the Global Business Summit on Healthcare and Life Science”, will focus on the challenges facing healthcare delivery around the world – in both developed and emerging economies – and will discuss and debate the ways in which transformational change in healthcare can be achieved through collaboration between industry, academia and healthcare providers. The event is being hosted by Lord Green of Hurstpierpoint, Minister of State for Trade and Investment and Professor Lord Darzi of Denham, UK Business Ambassador for the Life Sciences and Chair of the Institute of Global Health Innovation at Imperial College London. The one-day gathering will bring together an impressive cadre of speakers joined by top industrialists and entrepreneurs, eminent clinicians and researchers, leaders from the UK’s NHS and Health Ministers from around the world. Key themes explored during the summit will include translational research to develop novel therapeutics and medical technologies, and the expanding role of informatics and digital technology in healthcare delivery. The seminar programme will also consider how the UK is contributing to life sciences research and healthcare development at an international level.
Professor Toumazou’s presentation, “Disposable Semiconductor Healthcare – From the bedside to point of care genetics” will explore how a revolution in genetics and molecular biology is being driven by the confluence of advances in life science and semiconductor-based technologies. A key disruptive innovation that will be highlighted is the first label-free DNA amplification and detection based upon Ion-Sensitive, Field-Effect Transistor technology, which is enabling – for the first time – the creation of on-the-spot DNA diagnostic tests. Professor Toumazou will examine the technology trends and business models for rapid, lab-free and pipette-free DNA diagnostic testing, and the transformative opportunities it presents in global healthcare provision.
DNA Electronics, a spin-out of Imperial College London, was founded by Professor Toumazou following his invention of the company’s core technology that allows CMOS transistors to be switched on and off with DNA – the key invention enabling semiconductor-based sequencing. Prof. Toumazou’s innovation has culminated in the world’s first DNA logic on standard CMOS technology. DNA Electronics has worldwide non-exclusive licensing agreements with Roche’s 454 Life Sciences and Ion Torrent (Life Technologies Inc.) for the field of semiconductor sequencing, enabling these global leaders to access certain parts of the DNA Electronics proprietary technology portfolio. In March 2012, DNA Electronics announced that it is licensing its ground-breaking Genalysis® technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.
To download the full agenda of the Healthcare & Life Sciences Summit, please visit: http://www.ukti.gov.uk/download/330140/1/Life+Sciences+Summit+Agenda.pdf.html
-- ends –-
Notes to editors
About DNA Electronics
DNA Electronics is a developer of semiconductor solutions for real-time nucleic acid detection which enables faster, simpler and more cost-effective DNA analysis platforms. The company’s IP portfolio includes techniques for monitoring nucleotide insertions using ion-sensitive transistors, enabling label-free electronic DNA sequencing and diagnostics platforms using standard CMOS microchip technology. DNA Electronics (DNAe) has developed the Genalysis® platform of disposable silicon chip-based solutions for real-time nucleic acid sequence detection at the point of care, providing end users with technology as yet unavailable outside a laboratory.
DNAe’s Genalysis® portfolio of silicon-based point-of-care solutions delivers fast and accurate handheld gene tests with all the appeal of consumer electronics: anytime, anywhere. Interchangeable, disposable “lab-on-chip” cartridges can be tailored to any sequence of interest, making this a customizable semiconductor technology amenable to a wide variety of applications and markets. The ability to accurately detect a gene sequence in real-time using a standalone, fully portable, low power electronic readout presents disruptive new opportunities in diagnostics, data capture and therapy.
For more information: http://www.dnae.co.uk